Arturo Molina
2021
In 2021, Arturo Molina earned a total compensation of $2.6M as M.S., FACP, Chief Medical Officer at SUTRO BIOPHARMA, a 125% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $202,068 |
|---|---|
| Option Awards | $898,200 |
| Salary | $481,113 |
| Stock Awards | $1,055,500 |
| Other | $8,646 |
| Total | $2,645,527 |
Molina received $1.1M in stock awards, accounting for 40% of the total pay in 2021.
Molina also received $202.1K in non-equity incentive plan, $898.2K in option awards, $481.1K in salary and $8.6K in other compensation.
Rankings
In 2021, Arturo Molina's compensation ranked 4,929th out of 12,415 executives tracked by ExecPay. In other words, Molina earned more than 60.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,929 out of 12,415 | 60th |
Division Manufacturing | 2,063 out of 5,505 | 63rd |
Major group Chemicals And Allied Products | 874 out of 2,375 | 63rd |
Industry group Drugs | 783 out of 2,096 | 63rd |
Industry Biological Products, Except Diagnostic Substances | 198 out of 449 | 56th |
Source: SEC filing on April 22, 2022.
Molina's colleagues
We found four more compensation records of executives who worked with Arturo Molina at SUTRO BIOPHARMA in 2021.